"We can choose to build on the foundation that peptides like BPC-157n have given us and find a responsible way forward - one where patients stay under a clinician's care, where that care is monitored and studied, and where we steadily get better at how we use these therapies in the service of human health," Anant Vinjamoori, Hims' chief medical officer, said at Thursday's meeting
It is control
Unknown Cancer Risks: Modulating the immune system could potentially affect cancer surveillance mechanisms
You are not advised to self-administer this injection
PubMed Seiwerth, S., Rucman, R., Turkovic, B., Sever, M., Klicek, R., Radic, B., Drmic, D., Stupnisek, M., Misic, M., Vuletic, L.B., Sikiric, P
The patients received intravenous injections of BPC 157